DHRDanaher Corporation

Health care · Industrial Instruments · NYSE

Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. 10-K, Item 1

Employees: 60,000
Headquarters: Washington, DC
CEO: Rainer Blair
Next results: around Jan 11, 2027

Compare with peers → Embed

RevenueFY2016–25 $24.6B+2.9% FY2024: $23.9B 10-K FY2025 · XBRL Net incomeFY2016–25 $3.6B−7.3% FY2024: $3.9B 10-K FY2025 · XBRL Free cash flowFY2016–25 $5.3B−0.7% FY2024: $5.3B 10-K FY2025 · XBRL Operating marginFY2016–25 19.1%−1.3 pts 16.2% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 24, 2026 against Feb 20, 2025

Area	What changed	Source
Risk factors	6 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 24, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-20. Quoted as filed.

Our ability to grow revenues, earnings and cash flow at or above our historic rates depends in part upon our ability to identify and successfully acquire and integrate businesses at appropriate prices and realize anticipated synergies, and to make appropriate investments that support our long-term strategy. Over the past several years…
10-K, Item 1A

All 6 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +10.6% vs revenue +2.9% (+7.7 pts)
✓
Cash from operations $6.4B vs net income $3.6B (FY ending 2025-12-31)
✓
Inventory +6.8% vs revenue +2.9% (+3.9 pts)
✓
Same auditor in both 10-Ks: Ernst & Young LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Uncertain Tax Positions
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Oct 21, 20268-K Quarterly results 8-K item 2.02
Oct 21, 202610-Q Quarterly report (10-Q) period ended Sep 25, 2026
Oct 13, 20268-K Director or officer change, Other events 8-K items 5.02, 8.01

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on DHR in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DHR/export.csv") into a cell.